CRISM Therapeutics Corporation
CRTX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £479 | £1,282 | £2,354 | £4,384 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £0 | £0 | £0 | £0 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £1,648 | £408 | £556 | £402 |
| Total Curr. Assets | £2,127 | £1,690 | £2,910 | £4,786 |
| Property Plant & Equip (Net) | £60 | £52 | £76 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £194 | £74 | £67 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £6 | £0 |
| Other NC Assets | £0 | £0 | £2 | £0 |
| Total NC Assets | £254 | £126 | £150 | £0 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £2,381 | £1,816 | £3,060 | £4,786 |
| Liabilities | – | – | – | – |
| Payables | £144 | £29 | £191 | £471 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £439 | £312 | £253 | £191 |
| Total Curr. Liab. | £583 | £341 | £444 | £662 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £583 | £341 | £444 | £662 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £90,898 | £66,225 | £87,188 | £80,794 |
| Retained Earnings | -£2,935 | -£1,208 | -£776 | -£80,948 |
| AOCI | -£90,778 | £0 | -£88,043 | £0 |
| Other Equity | £4,612 | -£63,542 | £4,247 | £4,278 |
| Total Equity | £1,798 | £1,475 | £2,617 | £4,124 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £2,381 | £1,816 | £3,060 | £4,786 |
| Net Debt | -£479 | -£1,282 | -£2,354 | -£4,384 |